| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |